BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Thursday reported a loss of $3.59 billion in its second quarter.
The Boston-based company said it had a loss of $13.92 per share. Losses, adjusted for one-time gains and costs, were $12.83 per share.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $11.50 per share.
The drugmaker posted revenue of $2.65 billion in the period, meeting Street forecasts.
Vertex expects full-year revenue in the range of $10.65 billion to $10.85 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
/Broadcom%20Inc%20logo%20on%20building-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
